Carboplatin hypersensitivity in relapsed ovarian carcinoma: a therapeutic challenge (Record no. 35235)

000 -LEADER
fixed length control field 01720pab a2200361 454500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150901b2014 xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency Tata Memorial Hospital
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number
Item number
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Pandey A
245 ## - TITLE STATEMENT
Title Carboplatin hypersensitivity in relapsed ovarian carcinoma: a therapeutic challenge
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc. 2014
300 ## - PHYSICAL DESCRIPTION
Extent 17-20
490 ## - SERIES STATEMENT
Series statement
Volume/sequential designation Vol 35 Issues 1
520 ## - SUMMARY, ETC.
Summary, etc. Carboplatin and paclitaxel as doublet are the standard therapeutic option for advanced stage ovarian carcinoma in the first line as well as relapse. Carboplatin with its better toxicity profile has replaced cisplatin as the first line drug. However, increase in incidence of carboplatin hypersensitivity is alarming. Severity of carboplatin hypersensitivity varies from a mild rash to life-threatening reactions. With an increase in the number of cycles the risk of hypersensitivity reactions increase, which jeopardizes the use of this highly effective drug in a significant proportion of patients. Prompt diagnosis and rapid therapeutic rescue are the key in severe life-threatening reactions. Managing patients with carboplatin hypersensitivity and planning subsequent therapy is thus a therapeutic challenge.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Carboplatin, Desensitization, Hypersensitivity,,
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Ghosh J
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Ghosh J
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Singh A
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Pandita V
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Bhosale B
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name dr_jyotibajpai@yahoo.co.in
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Bajpai J
773 ## - HOST ITEM ENTRY
Main entry heading Indian Journal of Medical and Pediatric Oncology
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a 25006278
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a Review
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a India
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a Medical Oncology
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a TMH
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a TMC
Holdings
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Cost, normal purchase price Full call number Barcode Date last seen Price effective from Koha item type
        Tata Memorial Hospital Tata Memorial Hospital 2014-07-10 0.00 AR15177 2015-09-02 2015-09-02 Articles

Powered by Koha